M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Renovaro Inc. to acquire BioSymetrics
Announced Feb 26, 2025 · Closed Apr 8, 2025 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Renovaro Inc. (RENB)
- Target
- BioSymetrics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Apr 8, 2025
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations